473 related articles for article (PubMed ID: 7812973)
1. Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines.
Vilner BJ; John CS; Bowen WD
Cancer Res; 1995 Jan; 55(2):408-13. PubMed ID: 7812973
[TBL] [Abstract][Full Text] [Related]
2. Rat liver and kidney contain high densities of sigma 1 and sigma 2 receptors: characterization by ligand binding and photoaffinity labeling.
Hellewell SB; Bruce A; Feinstein G; Orringer J; Williams W; Bowen WD
Eur J Pharmacol; 1994 Jun; 268(1):9-18. PubMed ID: 7925616
[TBL] [Abstract][Full Text] [Related]
3. Targeting sigma receptor-binding benzamides as in vivo diagnostic and therapeutic agents for human prostate tumors.
John CS; Vilner BJ; Geyer BC; Moody T; Bowen WD
Cancer Res; 1999 Sep; 59(18):4578-83. PubMed ID: 10493511
[TBL] [Abstract][Full Text] [Related]
4. A sigma-like binding site in rat pheochromocytoma (PC12) cells: decreased affinity for (+)-benzomorphans and lower molecular weight suggest a different sigma receptor form from that of guinea pig brain.
Hellewell SB; Bowen WD
Brain Res; 1990 Sep; 527(2):244-53. PubMed ID: 2174717
[TBL] [Abstract][Full Text] [Related]
5. Discrepancies in characterization of sigma sites in the mouse central nervous system.
Kovács KJ; Larson AA
Eur J Pharmacol; 1995 Oct; 285(2):127-34. PubMed ID: 8566130
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of 5-HT3 binding sites in NG108-15, NCB-20 neuroblastoma cells and rat cerebral cortex using [3H]-quipazine and [3H]-GR65630 binding.
Sharif NA; Wong EH; Loury DN; Stefanich E; Michel AD; Eglen RM; Whiting RL
Br J Pharmacol; 1991 Apr; 102(4):919-25. PubMed ID: 1830236
[TBL] [Abstract][Full Text] [Related]
7. 1,3-Di(2-[5-3H]tolyl)guanidine labels more than one site in rat forebrain.
Codd EE; Shank RP
Eur J Pharmacol; 1992 Jul; 217(2-3):149-52. PubMed ID: 1425936
[TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of two sigma-like binding sites in the mouse neuroblastoma x rat glioma hybrid cell line NG108-15.
Georg A; Friedl A
J Pharmacol Exp Ther; 1991 Nov; 259(2):479-83. PubMed ID: 1658298
[TBL] [Abstract][Full Text] [Related]
9. Characterization of specific binding sites for [3H]-1,3-di-o-tolyl-guanidine (DTG) in the rat glioma cell line C6-BU-1.
Georg A; Friedl A
Glia; 1992; 6(4):258-63. PubMed ID: 1464457
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a (+)-azidophenazocine-sensitive sigma receptor on splenic lymphocytes.
Garza HH; Mayo S; Bowen WD; DeCosta BR; Carr DJ
J Immunol; 1993 Nov; 151(9):4672-80. PubMed ID: 7691955
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo expression of opioid and sigma receptors in rat C6 glioma and mouse N18TG2 neuroblastoma cells.
Barg J; Thomas GE; Bem WT; Parnes MD; Ho AM; Belcheva MM; McHale RJ; McLachlan JA; Tolman KC; Johnson FE
J Neurochem; 1994 Aug; 63(2):570-4. PubMed ID: 8035181
[TBL] [Abstract][Full Text] [Related]
12. Recognition of muscarinic cholinergic receptors in human SK-N-SH neuroblastoma cells by quaternary and tertiary ligands is dependent upon temperature, cell integrity, and the presence of agonists.
Fisher SK
Mol Pharmacol; 1988 Apr; 33(4):414-22. PubMed ID: 3357485
[TBL] [Abstract][Full Text] [Related]
13. Irreversible blockade of sigma-1 receptors by haloperidol and its metabolites in guinea pig brain and SH-SY5Y human neuroblastoma cells.
Cobos EJ; del Pozo E; Baeyens JM
J Neurochem; 2007 Aug; 102(3):812-25. PubMed ID: 17419803
[TBL] [Abstract][Full Text] [Related]
14. Characterization of opioid, sigma, and phencyclidine receptors in the neuroblastoma-brain hybrid cell line NCB-20.
Kushner L; Zukin SR; Zukin RS
Mol Pharmacol; 1988 Nov; 34(5):689-94. PubMed ID: 2848188
[TBL] [Abstract][Full Text] [Related]
15. Modulation of cellular calcium by sigma-2 receptors: release from intracellular stores in human SK-N-SH neuroblastoma cells.
Vilner BJ; Bowen WD
J Pharmacol Exp Ther; 2000 Mar; 292(3):900-11. PubMed ID: 10688603
[TBL] [Abstract][Full Text] [Related]
16. Sigma1 recognition sites in rabbit iris-ciliary body: topical sigma1-site agonists lower intraocular pressure.
Bucolo C; Campana G; Di Toro R; Cacciaguerra S; Spampinato S
J Pharmacol Exp Ther; 1999 Jun; 289(3):1362-9. PubMed ID: 10336527
[TBL] [Abstract][Full Text] [Related]
17. Sigma binding site ligands inhibit cell proliferation in mammary and colon carcinoma cell lines and melanoma cells in culture.
Brent PJ; Pang GT
Eur J Pharmacol; 1995 May; 278(2):151-60. PubMed ID: 7671999
[TBL] [Abstract][Full Text] [Related]
18. Differential solubilization of rat liver sigma 1 and sigma 2 receptors: retention of sigma 2 sites in particulate fractions.
Torrence-Campbell C; Bowen WD
Eur J Pharmacol; 1996 May; 304(1-3):201-10. PubMed ID: 8813603
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, in vitro pharmacologic characterization, and preclinical evaluation of N-[2-(1'-piperidinyl)ethyl]-3-[125I]iodo-4-methoxybenzamide (P[125I]MBA) for imaging breast cancer.
John CS; Bowen WD; Fisher SJ; Lim BB; Geyer BC; Vilner BJ; Wahl RL
Nucl Med Biol; 1999 May; 26(4):377-82. PubMed ID: 10382840
[TBL] [Abstract][Full Text] [Related]
20. Oocytes from Xenopus laevis contain an intrinsic sigma 2-like binding site.
Patterson TA; Connor M; Appleyard SM; Chavkin C
Neurosci Lett; 1994 Oct; 180(2):159-62. PubMed ID: 7700571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
